Director, Scientific Affairs
Celerion
Sabina Paglialunga, PhD is Director, Scientific Affairs at Celerion. In this key leadership position, she provides scientific, operational and regulatory support for early clinical studies and strategic initiatives. Sabina serves as a subject matter expert in metabolic diseases such as obesity, metabolic dysfunction associated steatohepatitis (MASH) and type 2 diabetes as well as renal and hepatic impairment PK studies, where she has published extensively in these areas. She joined Celerion in 2015 and has held several roles with increasing responsibility. Sabina received her PhD from the Biochemistry Department at McGill University, Canada and her training also includes three Postdoctoral Fellowships.